AUPH
NASDAQ · Biotechnology
Aurinia Pharmaceuticals Inc
$16.67
+0.06 (+0.36%)
Open$16.73
Previous Close$16.61
Day High$16.74
Day Low$16.65
52W High$19.25
52W Low$10.34
Volume—
Avg Volume812.3K
Market Cap2.26B
P/E Ratio7.18
EPS$2.29
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+143.8% upside
Current
$16.67
$16.67
Target
$40.64
$40.64
$34.07
$40.64 avg
$61.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 272.82M | 212.62M | 554.79M |
| Net Income | 276.81M | 194.17M | -143,878,553 |
| Profit Margin | 101.5% | 96.4% | -25.9% |
| EBITDA | 119.86M | 88.74M | -183,212,536 |
| Free Cash Flow | — | — | -112,933,113 |
| Rev Growth | +28.3% | +28.3% | +6.7% |
| Debt/Equity | 0.12 | 0.12 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |